Tenecteplase treatment registry for acute ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This registry looks at how people with an acute ischemic stroke (a blocked artery) are treated when they receive tenecteplase through a vein. It may help doctors understand outcomes and care for different stroke timing situations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had an acute blocked-artery stroke confirmed on a CT or MRI scan.
- The stroke symptoms started within 270 minutes, or your stroke was found by special scan criteria (like wake-up stroke).
- You received tenecteplase through an IV (a medicine given through a vein).
- Your doctors said you can safely receive IV clot-busting medicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a clot-busting drug called tenecteplase for people having a disabling ischemic stroke (a clot blocking blood flow to the brain). It aims to see if the drug can help improve recovery when given within 4.5 hours of symptoms starting.
This registry tracks how well tenecteplase (a clot-busting medication) works when given more than 4.5 hours after a stroke starts. Researchers want to learn if treating strokes this late can still help patients recover.
This study tests a clot-dissolving drug called tenecteplase given directly into the artery after a mechanical thrombectomy (clot removal). The goal is to see if it helps improve blood flow to the small vessels in the brain after the main clot is removed.
This trial tests a clot-busting drug called tenecteplase, given directly into the blocked artery, for people who have had a stroke caused by a medium-sized brain vessel blockage within the last 24 hours. It aims to see if this treatment is safe and effective in improving recovery.
This trial tests a clot-busting drug called tenecteplase given directly into the brain artery for people having a moderate stroke caused by a blockage in a medium-sized blood vessel. The goal is to see if it helps improve recovery when given within 24 hours of stroke symptoms starting.
This trial tests a clot-dissolving medicine called tenecteplase for people who had a stroke more than 4.5 hours ago. It may help you recover if given later than usual.
Hear when a new Stroke, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.